Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery

Summary

Evogene Ltd. and Tel Aviv University's Blavatnik Center for Drug Discovery announced a joint initiative to accelerate AI-driven small-molecule drug discovery, combining the center's experimental infrastructure with Evogene's computational chemistry and AI capabilities.